Literature DB >> 36131307

Correction: Effectiveness of a training intervention to improve the management of vertigo in primary care: a multicentre cluster-randomised trial, VERTAP.

Jenniffer Elizabeth Pérez Patiño1,2, José Lluís Ballvé Moreno3,4,5, Yolanda Rando Matos2,6, Jesús Almeda Ortega2,7, Oriol Cunillera Puértolas2,7, Ricard Carrillo Muñoz2,8, Iván Villar Balboa2,8, Xavier González Compta2,9,10, Olga Lucía Arias Agudelo1,2, Sebastiá Calero Muñoz2,6,8, Vanessa Monforte Rodríguez2,11, Anna Navarro Cortes2,12, Eva Peguero Rodríguez2,13,14.   

Abstract

Entities:  

Year:  2022        PMID: 36131307      PMCID: PMC9490898          DOI: 10.1186/s13063-022-06759-y

Source DB:  PubMed          Journal:  Trials        ISSN: 1745-6215            Impact factor:   2.728


× No keyword cloud information.
Correction: Trials 23, 208 (2022) https://doi.org/10.1186/s13063-022-06548-7 Following the publication of the original article [1], the authors have requested that we add the below text to the Funding section: The project has received a research grant from the Instituto de Salud Carlos III, of the Ministry of Economy and Competitiveness (Spain), awarded in the 2019 call within the Action of the Health Strategy 2013-2016, within the National Programme of Research oriented to the Challenges of Society, within the National Plan for Technical, Scientific and Innovation Research 2013-2016, with reference PI19/00736, co-financed with ERDF funds from the European Union (European Regional Development Fund). The original article has been corrected.
  1 in total

1.  Effectiveness of a training intervention to improve the management of vertigo in primary care: a multicentre cluster-randomised trial, VERTAP.

Authors:  Jenniffer Elizabeth Pérez Patiño; José Lluís Ballvé Moreno; Yolanda Rando Matos; Jesús Almeda Ortega; Oriol Cunillera Puértolas; Ricard Carrillo Muñoz; Iván Villar Balboa; Xavier González Compta; Olga Lucía Arias Agudelo; Sebastiá Calero Muñoz; Vanessa Monforte Rodríguez; Anna Navarro Cortes; Eva Peguero Rodríguez
Journal:  Trials       Date:  2022-07-29       Impact factor: 2.728

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.